Newron Pharmaceuticals SpA (NP5) Q2 2026 Earnings Report
DE:NP5 Q2 2026 EPS Results
- Actual EPS
- -EUR 0.80
- Consensus EPS
- -EUR 0.19
- Beat/Miss
- Missed by -EUR 0.61
- One Year Ago EPS
- EUR 0.00
DE:NP5 Q2 2026 Revenue Results
- Actual Revenue
- EUR 3.16M
- Expected Revenue
- EUR 5.68M
- Beat/Miss
- Missed by -EUR 2.52M
- YoY Revenue Growth
- -73.87%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 09/22/2026
- Time
- Before Open
- Conference Call
- Tuesday, September 22, 2026
DE:NP5 Upcoming Earnings
Newron Pharmaceuticals SpA's next earnings date is estimated for March 16, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:NP5 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 16, 2027 | 2026 (Q4) | -0.77- | -0.66 | ― | ― |
| Sep 22, 2026 | 2026 (Q2) | -0.19-0.80 | 0 | ― | |
| Mar 24, 2026 | 2025 (Q4) | -0.08-0.66 | 1.2 | -154.95% (-1.86) | |
| Sep 16, 2025 | 2025 (Q2) | -0.410.00 | -0.51 | 100.00% (+0.51) | |
| Apr 01, 2025 | 2024 (Q4) | ―1.29 | -0.54 | 341.16% (+1.83) | |
| Sep 19, 2024 | 2024 (Q2) | ―-0.51 | -0.39 | -30.77% (-0.12) | |
| Mar 19, 2024 | 2023 (Q4) | ―-0.54 | -0.52 | -2.47% (-0.01) | |
| Aug 04, 2023 | 2023 (Q2) | ―-0.39 | -0.48 | 18.75% (+0.09) | |
| Mar 14, 2023 | 2022 (Q4) | ―-0.52 | -0.38 | -39.26% (-0.15) | |
| Sep 15, 2022 | 2022 (Q2) | ―-0.48 | -0.51 | 5.88% (+0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
